4/16/2019Tianjin Tanabe and Servier China Enter Strategic Co-promotion Deal for...

4/16/2019NHC Publishes Report on Status Quo of Chinese Antibiotic Management an...

4/16/2019MSK-CTONG Collaboration Will Accelerate US-China Clinical Trials

4/16/2019GSK-Pfizer Consumer Healthcare JV to Focus on the U.S. and China Marke...

4/16/2019CStone Gains Chinese IND Approval for Avapritinib Phase I/II Bridging ...

4/16/2019LSK BioPharma and Hengrui Medicine Announce FDA Clearance to Initiate ...

4/16/2019WuXi Bio Set to Lose Contract Manufacturing of First Antibody-based HI...

4/16/2019iCarbonX May Have to Divest from US Firm over National Security Concer...

4/16/2019Chi-Med Files IPO in Hong Kong, Aiming to Raise $500M

4/16/2019Bayer Pharma Hit with China-attributed Malware

4/16/2019GenScript Starts Construction of GenScript-Legend Biotech Commercial M...

4/16/2019China and Cuba Look to Enhance Cooperation in Biotech and Pharma

4/16/2019'Reverse Patent Trolls' Plague Big Pharma in China

4/15/2019Chinese Import of Medicine and Health Products Down in 2018 Due to Pri...

4/15/2019Ten Workers Killed in Plant Incident at Qilu Tianhe Huishi Pharma

4/15/2019Chairman of Sunflower Pharma Arrested for Murder

4/15/2019Hope Medicine Licenses Bayer's Human Antibody Targeting the PRL Recept...

4/12/2019China's Hansoh Pharma Re-files for Hong Kong IPO

4/12/2019Novartis Submits New Drug Application for Gilenya (Fingolimod Hydrochl...

4/12/2019CDE Seeks Comments on Draft ICH Guideline M10

4/12/2019Recent Executive Moves

4/12/2019Luqa Pharma and Ferrer Enter Agreement for Antibiotic Ozenoxacin in G...

4/11/2019Ant Financial Aims to Disrupt China’s Health Insurance Space with Mut...

4/11/2019NHSA Solicits Comments on Draft Rules for Use of Basic Medical Insuran...

4/11/2019CDE Publicizes Six More Drug Applications To Be Granted Priority Revie...

4/11/2019China Plans to Issue A New Set of Standards for Stem Cell Therapies

4/11/2019Synaffix Announces $125M License Agreement with Shanghai Miracogen

4/11/2019Catalent Opens 2nd Shanghai Facility to Optimize Clinical Supply Solut...

4/10/2019HitGen and Kaken Enter into License Agreement for Novel Drug Developme...

4/10/2019ReNeuron Licenses China Rights of Cell Therapy Programs to Fosun Pharm...

Page:301/790 Total number of articles:23678: [First][<<] [299] [300] [301] [302] [303] [>>] [End]